Core Scientific (CORZ) Change in Account Payables (2021 - 2026)

Core Scientific (CORZ) has 6 years of Change in Account Payables data on file, last reported at $5.9 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Account Payables rose 141.09% year-over-year to $5.9 million; the trailing twelve-month figure through Mar 2026 stood at $31.0 million (up 283.88% YoY), and the FY2025 full-year result was $10.8 million, up 187.86% from the prior year.
• Change in Account Payables declined to $5.9 million in Q1 2026, from $28.4 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $86.1 million in Q4 2023 to a low of -$14.3 million in Q1 2025.
• A 5-year average of $8.8 million and a median of -$160000.0 in 2024 frame the typical range for Change in Account Payables.
• Peak annual rise in Change in Account Payables reached 4593.67% in 2025, while the deepest fall reached 674.38% in 2025.
• Tracing CORZ's Change in Account Payables over 5 years: stood at $23.8 million in 2022, then surged by 262.56% to $86.1 million in 2023, then tumbled by 100.73% to -$632000.0 in 2024, then jumped by 4593.67% to $28.4 million in 2025, then slumped by 79.32% to $5.9 million in 2026.
• Business Quant data shows CORZ's Change in Account Payables at $5.9 million in Q1 2026, $28.4 million in Q4 2025, and -$1.2 million in Q3 2025.